Get startedLog in
    Picture of Churchill Capital XI logo

    CCXIU — Churchill Capital XI News Story

    0.000.00%
    us flag iconLast trade - 00:00
    FinancialsSpeculativeMid CapNeutral
    All News

    Brief: ChemoCentryx Inc Announces FDA Approval Of Tavneos (AVACOPAN)

    Picture of Churchill Capital XI logoChurchill Capital XI
    08/10/2021 12:06
    Oct 8 (Reuters) - ChemoCentryx Inc  CCXI.O :
    * CHEMOCENTRYX ANNOUNCES FDA APPROVAL OF TAVNEOS™ (AVACOPAN)
IN
ANCA-ASSOCIATED VASCULITIS
    * CHEMOCENTRYX INC - REGULATORY DECISION FOR TAVNEOS IN
EUROPE
FOLLOWING EUROPEAN MEDICINES AGENCY (EMA) REVIEW IS EXPECTED BY
END OF 2021

Source text for Eikon:  ID:nGNX7921Cv 
Further company coverage:  CCXI.O

    Recent news on Churchill Capital XI

    See all news